Follow
Gutiérrez-Pizarraya Antonio
Gutiérrez-Pizarraya Antonio
PhD epidemiología
Verified email at juntadeandalucia.es
Title
Cited by
Cited by
Year
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
J Garnacho-Montero, A Gutiérrez-Pizarraya, A Escoresca-Ortega, ...
Intensive care medicine 40, 32-40, 2014
4582014
Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis
J Garnacho-Montero, MJ Huici-Moreno, A Gutiérrez-Pizarraya, I López, ...
Critical care 18 (3), 1-9, 2014
1752014
Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre.
JM Cisneros, O Neth, MV Gil‐Navarro, JA Lepe, F Jiménez‐Parrilla, ...
Clin Microbiol Infect, 1469-0691.12191, 2013
1472013
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii
J Garnacho-Montero, R Amaya-Villar, A Gutiérrez-Pizarraya, ...
Chemotherapy 59 (3), 225-231, 2013
982013
Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality
J Garnacho-Montero, A Gutiérrez-Pizarraya, A Escoresca-Ortega, ...
Critical care 19, 1-8, 2015
962015
Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave
A Gutiérrez-Pizarraya, P Pérez-Romero, R Alvarez, TA Aydillo, ...
Journal of Infection 65 (5), 423-430, 2012
952012
Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections: a quasi-experimental study …
J Molina, G Peñalva, MV Gil-Navarro, J Praena, JA Lepe, ...
Clinical Infectious Diseases 65 (12), 1992-1999, 2017
772017
Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect …
F Fernández-Cuenca, M Tomás, FJ Caballero-Moyano, G Bou, ...
Journal of Antimicrobial Chemotherapy 70 (12), 3222-3229, 2015
612015
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority …
52*
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia
J Garnacho-Montero, R Amaya-Villar, C Ferrándiz-Millón, A Díaz-Martín, ...
Expert review of anti-infective therapy 13 (6), 769-777, 2015
432015
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant …
T Amat, A Gutierrez-Pizarraya, I Machuca, I Gracia-Ahufinger, ...
Clinical Microbiology and Infection 24 (6), 630-634, 2018
402018
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
C Morata-Tarifa, MM Macías-Sánchez, A Gutiérrez-Pizarraya, ...
Stem Cell Research & Therapy 11, 1-12, 2020
382020
Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients
J Molina, I Penuela, JA Lepe, A Gutierrez-Pizarraya, MJ Gomez, ...
Journal of Infection 66 (2), 155-162, 2013
352013
Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality
J Garnacho-Montero, A Gutiérrez-Pizarraya, A Díaz-Martín, ...
Enfermedades infecciosas y microbiologia clinica 34 (9), 551-558, 2016
282016
Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive …
J Garnacho-Montero, C León-Moya, A Gutiérrez-Pizarraya, ...
Journal of critical care 48, 172-177, 2018
212018
Epidemiology, Clinical Features, and Prognosis of Elderly Adults with Severe Forms of Influenza A (H 1 N 1)
J Garnacho‐Montero, A Gutiérrez‐Pizarraya, JA Márquez, R Zaragoza, ...
Journal of the American Geriatrics Society 61 (3), 350-356, 2013
212013
Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis
A Gutiérrez-Pizarraya, M Leone, J Garnacho-Montero, C Martin, ...
Expert Review of Clinical Pharmacology 10 (4), 457-465, 2017
202017
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
J Macías, A Pinilla, FA Lao-Dominguez, A Corma, E Contreras-Macias, ...
Scientific Reports 10 (1), 20958, 2020
142020
Sequential changes of NLRP3 inflammasome activation in sepsis and its relationship with death
J Garnacho-Montero, I Palacios-García, A Díaz-Martín, ...
Shock 54 (3), 294-300, 2020
122020
Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool
G Martín-Gutiérrez, C Martín-Pérez, A Gutiérrez-Pizarraya, JA Lepe, ...
Enfermedades infecciosas y microbiologia clinica (English ed.) 35 (10), 638-644, 2017
122017
The system can't perform the operation now. Try again later.
Articles 1–20